Us Congress 2025-2026 Regular Session

House Energy and Commerce Committee Bills & Legislation (Page 13)

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB950

Introduced
2/4/25  
Saving Seniors Money on Prescriptions ActThis bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs.Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e.g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to the Centers for Medicare & Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB920

Introduced
2/4/25  
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB936

Introduced
2/4/25  
Medicaid Improvement and State Flexibility Act of 2025This bill authorizes states to approve their own experimental, pilot, or demonstration project under Medicaid if the project provides certain benefits involving electronic benefits transfer (EBT) cards. (Currently, the Centers for Medicare & Medicaid Services approves Medicaid demonstration projects; such projects are also known as Section 1115 Demonstrations.)Specifically, the project must provide enrollees who elect to participate with an EBT card to purchase primary care services; enrollees must receive any remaining balance at the end of the year in the form of a cash payment and must also obtain catastrophic health insurance.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1019

Introduced
2/5/25  
Medicaid Program Improvement Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HR111

Introduced
2/5/25  
Expressing support for blockchain technology and digital assets.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1010

Introduced
2/5/25  
BADGES for Native Communities Act Bridging Agency Data Gaps and Ensuring Safety for Native Communities Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB999

Introduced
2/5/25  
Right to Contraception Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1051

Introduced
2/6/25  
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1060

Introduced
2/6/25  
Modern Authentication of Pharmaceuticals Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1085

Introduced
2/6/25  
CARGO Act of 2025 Cease Animal Research Grants Overseas Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1100

Introduced
2/6/25  
STOPP Act Stop the Opioid Pill Presser and Fentanyl Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1096

Introduced
2/6/25  
HOPE and Mental Wellbeing Act of 2025 Helping Out Patients for Emotional and Mental Wellbeing Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1066

Introduced
2/6/25  
Ending Green Giveaways Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB198

Introduced
2/27/23  
Drug Pricing Transparency and Accountability Act This bill establishes a two-year moratorium on allowing new, non-rural hospitals and associated child sites to participate in the 340B drug pricing program; during the moratorium, the Department of Health and Human Services must issue regulations with specified program eligibility standards. The bill also requires additional reporting relating to program participation, eligibility, and costs.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB81

Introduced
1/3/25  
Travel Mask Mandate Repeal Act of 2025This bill prohibits federal agencies from imposing a mandate related to COVID-19 that requires the use of face masks on conveyances (e.g., planes, trains, and buses) and at transportation hubs.Further, the bill nullifies (1) the emergency order issued by the Centers for Disease Control and Prevention (CDC) on January 29, 2021, that mandates such use of face masks on public and commercial conveyances and at transportation hubs, and (2) orders and directives of the Transportation Security Administration (TSA) that relate to the CDC order.As background, the CDC and TSA ceased enforcement of the emergency order following an April 18, 2022, court order. Further, the COVID-19 public health emergency expired on May 11, 2023.